Previous close | 1.6600 |
Open | 1.7000 |
Bid | 1.6400 x 1000 |
Ask | 1.6500 x 800 |
Day's range | 1.6300 - 1.7300 |
52-week range | 0.5000 - 2.5300 |
Volume | |
Avg. volume | 605,950 |
Market cap | 55.836M |
Beta (5Y monthly) | 2.00 |
PE ratio (TTM) | 9.17 |
EPS (TTM) | 0.1800 |
Earnings date | 27 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Kin Communications Inc. ("Kin"), a leading full-service investor relations agency, has joined forces with NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen M.D.''), a leader in needle-free drug delivery, to raise funds in order to purchase insulin to be administered and delivered with NuGen M.D's needle-free injection device also known as InsuJet™, to Ukrainian diabetics urgently in need of daily insulin injections to stay alive.